Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Malaria remains a major global health challenge, driven by the emergence and spread of resistance to frontline therapies. The dynamics of antimalarial drug resistance are shaped by parasite biology, ...

Artemisinin and its semisynthetic derivatives have underpinned global malaria control for over two decades. Derived from the sweet wormwood plant, these endoperoxide compounds exhibit rapid parasite ...

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...

Malaria is a constant threat for nearly half of the world’s population, and people who travel to those areas are also at risk. Although the short-term side effects of prophylactic drugs are ...

WASHINGTON – Although the immediate side effects of antimalarial drugs are widely recognized, few studies were designed specifically to examine health problems that might occur or persist months or ...

A new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a new report. A new antimalarial drug is being introduced at a dose ...

Rectal artesunate (RAS), a promising antimalarial drug, proves ineffective at saving the lives of young children suffering from severe malaria, according to the results of a new study conducted by the ...

Antimalarials discovered over the last century have proved effective in fighting malaria. But the parasites that cause the disease often develop resistance to these drugs, leaving a demand for new ...

Herbal remedies have been used for many centuries and are the predecessors to many of the drug compounds we use today. For example, the Ebers Papyrus from 2900 BC is an Egyptian pharmaceutical record ...

A new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a report published today in eLife. The study suggests that the current ...

(CN) — A U.S. military veteran filed a federal class action lawsuit Thursday against the makers of an antimalarial drug distributed to military forces, claiming the drug made tens of thousands of ...